Health Officials Launch Urgent Study Amid Pancreatitis Concerns Linked to Popular Weight Loss Medications
London, England — Health authorities are launching an urgent investigation into serious health complications reportedly linked to medications used for weight loss and diabetes management. Numerous individuals have raised concerns about pancreatic issues associated with glucagon-like peptide-1 (GLP-1) receptor agonists, prompting a formal study into their potential side effects. The Medicines and Healthcare products Regulatory … Read more